Update: Checkmate details bleak future if $250M Regeneron merger does not close
Update: Checkmate details bleak future if $250M Regeneron merger does [...]
3 UK pharma companies go broke, costing 1,000 employees their jobs: reports
3 UK pharma companies go broke, costing 1,000 employees their [...]
Bora scoops up plant from Eden, the company at the center of the Genentech theft saga
Bora scoops up plant from Eden, the company at the [...]
Adagio still hopes to build omicron offense for lead COVID-19 therapy
Adagio still hopes to build omicron offense for lead COVID-19 [...]
Novartis’ Sandoz strikes at Roche with first US generic of blockbuster Esbriet
Novartis’ Sandoz strikes at Roche with first US generic of [...]
Mitsubishi Tanabe scores FDA nod for oral version of its ALS drug Radicava
Mitsubishi Tanabe scores FDA nod for oral version of its [...]
BridgeBio adds another $110M to coffers with voucher sale a day after mega BMS deal
BridgeBio adds another $110M to coffers with voucher sale a [...]
Bristol Myers sells NY biologics plant for $160M to fuel Lotte’s drugmaking ambitions
Bristol Myers sells NY biologics plant for $160M to fuel [...]
FDA tags Editas’ thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic
FDA tags Editas’ thalassemia cell therapy an orphan drug as [...]
Roche’s TIGIT flop prompts GSK, iTeos to reevaluate next steps for rival drug
Roche’s TIGIT flop prompts GSK, iTeos to reevaluate next steps [...]